Stephen Locarnini
Director/Board Member at BIOTRON LIMITED
Net worth: 28 728 $ as of 2024-05-30
Stephen Locarnini active positions
| Companies | Position | Start | End |
|---|---|---|---|
| BIOTRON LIMITED | Director/Board Member | 2018-10-22 | - |
| Independent Dir/Board Member | 2018-10-22 | - | |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | Corporate Officer/Principal | - | - |
Career history of Stephen Locarnini
Former positions of Stephen Locarnini
| Companies | Position | Start | End |
|---|---|---|---|
ClearB Therapeutics, Inc.
 ClearB Therapeutics, Inc. BiotechnologyHealth Technology ClearB Therapeutics, Inc. is a company that focuses on therapeutics. The company is based in Concord, MA. The company was co-founded in 2017 by Morningside Ventures in collaboration with Professor Stephen Locarnini and the Victoria Infectious Diseases Reference Laboratory. Aileen Rubio has been the CEO of the company since 2018. | Founder | 2016-12-31 | - |
| Victorian Infectious Diseases Reference Laboratory | Corporate Officer/Principal | 1989-12-31 | - |
| World Health Organization Collaborating Centre | Director/Board Member | - | - |
Statistics
International
| Australia | 5 |
| United States | 2 |
Operational
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Independent Dir/Board Member | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| BIOTRON LIMITED | Health Technology |
| Private companies | 3 |
|---|---|
| World Health Organization Collaborating Centre | |
ClearB Therapeutics, Inc.
ClearB Therapeutics, Inc. BiotechnologyHealth Technology ClearB Therapeutics, Inc. is a company that focuses on therapeutics. The company is based in Concord, MA. The company was co-founded in 2017 by Morningside Ventures in collaboration with Professor Stephen Locarnini and the Victoria Infectious Diseases Reference Laboratory. Aileen Rubio has been the CEO of the company since 2018. | Health Technology |
| Victorian Infectious Diseases Reference Laboratory |
- Stock Market
- Insiders
- Stephen Locarnini
- Experience
